RPRX
Royalty Pharma plc · Healthcare
EVP & Chairman, Partnering Christopher Hite sold $7.3M of Royalty Pharma plc
Sold$7,345,471
$56.50Price
130,000Shares
−76%Stake
What RPRX did after the filing
- The stock from Mon, Jul 6 open, $57.78
- +3.3%
- S&P 500, same days
- +2.5%
Measured over 30 trading days, to the Aug 18 close.
Traded Tue, Jun 30. Filed Thu, Jul 2, 4:08 PM ET, after the close. Returns use the Jul 6 open and the Aug 18 close. Not investment advice.